Viewing Study NCT04923932


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-01 @ 2:03 AM
Study NCT ID: NCT04923932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2021-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Sponsor: Hutchison Medipharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module